Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc.

0001971532

Telomir Pharmaceuticals is a biotechnology company focused on developing Telomir-1, an oral small molecule designed to combat aging and chronic disease. Telomir-1 regulates essential metals, protects telomeres, and defends against oxidative stress and DNA damage. The aim is to address the root causes of disease progression, not just manage symptoms.

89
Meget Pålidelig
Tillidsscore

Officielt Register

Business.legalName
Telomir Pharmaceuticals, Inc.
CVR-nummer
0001971532
Momsnummer
872606031
Virksomhedsstatus
Active
Adresse
100 SE 2ND ST, MIAMI, FL 33131
Branchekoder
Pharmaceutical Preparations, 2834

Sidst verificeret: 1/2/2026

AI Kvalitetsanalyse

Branche
Biotechnology
SSL/HTTPS
Sikker
Professionel E-mail
Ja
Kontakt E-mail
info@telomirpharma.com

🌟 Lignende Troværdige Virksomheder

vTv Therapeutics Inc.

vTv Therapeutics Inc. logo
89/100 · Meget Pålidelig

vTv Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of diabetes patients. They focus on developing oral, small molecule drug candidates. Their lead candidate is cadisegliatin, a potential adjunctive therapy to insulin for type 1 diabetes. They are also exploring indications for type 2 diabetes and other chronic conditions.

3980 PREMIER DR, USA
Se profil

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. logo
86/100 · Meget Pålidelig

Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel immunotherapies using foreign patterns to trigger the innate immune system, which teaches the immune system to recognize and kill cancer. Bolt was founded in 2015.

900 CHESAPEAKE DRIVE, USA
Se profil

IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. logo
86/100 · Meget Pålidelig

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors.

825 INDUSTRIAL ROAD, USA
Se profil